BioSpace News Archive

Press Releases

Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance

June 8, 2026
·
6 min read
Press Releases

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

June 8, 2026
·
3 min read
Press Releases

IBA signs contract with a major U.S. academic medical center to install two Proteus®ONE proton therapy solutions

June 8, 2026
·
2 min read
Press Releases

Vivoryon Therapeutics N.V. to Report Q1 2026 Financial Results on June 11, 2026

June 8, 2026
·
2 min read
Press Releases

Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

June 8, 2026
·
10 min read
Press Releases

Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology

June 8, 2026
·
7 min read
Press Releases

Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector

June 8, 2026
·
12 min read
Press Releases

Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia

June 8, 2026
·
4 min read
Press Releases

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development

June 8, 2026
·
4 min read
Press Releases

Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026

June 8, 2026
·
6 min read